Exact Sciences, RedHill Biopharma & more — 3 GI company key notes

Here are three updates on GI companies from the past week:

Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.

Exact Sciences is sponsoring Fight Colorectal Cancer and PGA Tour professional Tom Lehman to promote Fight CRC.

RedHill Biopharma's Crohn's disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks.

More articles on gastroenterology:
Actor Matthew Perry undergoes tracheostomy in Los Angeles hospital — 5 insights
ASGE recognizes Metropolitan Gastroenterology Consultants — 3 insights
Dr. William Karnes: Key trends and challenges in GI today

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months